152 related articles for article (PubMed ID: 6286616)
21. Structural and Biochemical Insight into the Mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP Phosphodiesterase.
He Q; Wang F; Liu S; Zhu D; Cong H; Gao F; Li B; Wang H; Lin Z; Liao J; Gu L
J Biol Chem; 2016 Feb; 291(7):3668-81. PubMed ID: 26668313
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a human melanoma cell line (KHm-1) containing phosphodiesterase activity only for cyclic adenosine 3':5'-monophosphate.
King LE; Solomon SS; Hashimoto K
Cancer Res; 1978 Nov; 38(11 Pt 1):3879-85. PubMed ID: 29705
[No Abstract] [Full Text] [Related]
23. [Phosphodiesterases of cyclic GMP].
Wróblewska H; Gorczyca WA
Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of rat liver cyclic 3':5'-nucleotide phosphodiesterase by cyclic GMP is dependent on enzyme concentration.
Guan WR; Cheung WY
Arch Biochem Biophys; 1980 Oct; 204(1):191-8. PubMed ID: 6252844
[No Abstract] [Full Text] [Related]
25. Regulation of cyclic AMP and cyclic GMP in Morris hepatomas and liver.
Hickie RA
Adv Exp Med Biol; 1977 May 22-24; 92():451-88. PubMed ID: 24988
[No Abstract] [Full Text] [Related]
26. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
Hoskins B; Luong HB
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
[TBL] [Abstract][Full Text] [Related]
27. Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms.
Keravis TM; Wells JN; Hardman JG
Biochim Biophys Acta; 1980; 613(1):116-29. PubMed ID: 6246952
[TBL] [Abstract][Full Text] [Related]
28. 3':5'-cyclic-nucleotide phosphodiesterase in the bovine pituitary gland.
Nagasaka A; Ohkubo S; Hidaka H
Biochim Biophys Acta; 1983 Feb; 755(3):481-7. PubMed ID: 6297613
[TBL] [Abstract][Full Text] [Related]
29. Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites.
Erneux C; Miot F
Methods Enzymol; 1988; 159():520-30. PubMed ID: 2842616
[No Abstract] [Full Text] [Related]
30. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
31. Molecular determinants of cGMP binding to chicken cone photoreceptor phosphodiesterase.
Huang D; Hinds TR; Martinez SE; Doneanu C; Beavo JA
J Biol Chem; 2004 Nov; 279(46):48143-51. PubMed ID: 15331594
[TBL] [Abstract][Full Text] [Related]
32. Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brain.
Liang CM; Liu YP; Chabner BA
Biochem Pharmacol; 1980 Feb; 29(3):277-82. PubMed ID: 6244836
[No Abstract] [Full Text] [Related]
33. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
Beatty CH; Herrington PT; Bocek RM
Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
[TBL] [Abstract][Full Text] [Related]
34. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
Levin RM; Weiss B
Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
[No Abstract] [Full Text] [Related]
36. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
Kireeva NN; Bobruskin ID; Severin SE
Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
[TBL] [Abstract][Full Text] [Related]
37. Phosphodiesterases in neurodegenerative disorders.
Bollen E; Prickaerts J
IUBMB Life; 2012 Dec; 64(12):965-70. PubMed ID: 23129425
[TBL] [Abstract][Full Text] [Related]
38. Nerve growth factor increases the cyclic GMP level and activates the cyclic GMP phosphodiesterase in PC12 cells.
Laasberg T; Pihlak A; Neuman T; Paves H; Saarma M
FEBS Lett; 1988 Nov; 239(2):367-70. PubMed ID: 2460374
[TBL] [Abstract][Full Text] [Related]
39. Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.
Epstein PM; Mills JS; Ross CP; Strada SJ; Hersh EM; Thompson WJ
Cancer Res; 1977 Nov; 37(11):4016-23. PubMed ID: 198126
[No Abstract] [Full Text] [Related]
40. Theoretical analyses of the functioning of the high- and low-Km cyclic nucleotide phosphodiesterases in the regulation of the concentration of adenosine 3',5'-cyclic monophosphate in animal cells.
Fell DA
J Theor Biol; 1980 May; 84(2):361-85. PubMed ID: 6251314
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
